Sponsor
Allysta Pharmaceuticals Inc.
500 108th Avenue Northeast Suite 1100, 98004-5535, United States
About the sponsor
Clinical research is focused on nonalcoholic steatohepatitis (NASH) and related metabolic dysfunction in people with overweight or obesity, reflecting interest in liver-centered disease processes linked to excess body weight.
- NASH
- Fatty liver disease
- Metabolic liver injury
The sponsor’s research activity is centered on a therapeutic area where liver inflammation and metabolic imbalance intersect.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.